[1] | Boslem E, Meikle PJ, Biden TJ (2012) Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction. Islets 4: 177-187. doi:10.4161/isl.20102. PubMed: 22847494.
|
[2] | Lipina C, Hundal HS (2011) Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance. Diabetologia 54: 1596-1607. doi:10.1007/s00125-011-2127-3. PubMed: 21468641.
|
[3] | Alewijnse AE, Peters SL (2008) Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol 585: 292-302. doi:10.1016/j.ejphar.2008.02.089. PubMed: 18420192.
|
[4] | Hla T (2003) Signalling and biological actions of sphingosine 1-phosphate. Pharmacolpharmacological Research 47: 401-407. doi:10.1016/S1043-6618(03)00046-X.
|
[5] | Merrill AH (2002) De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 29: 25843-25846. PubMed: 12011104.
|
[6] | Hannun YA, Obeid LM (2002) The ceramide – centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 29: 25847-25850.
|
[7] | Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585: 193-201. doi:10.1016/S1388-1981(02)00341-4. PubMed: 12531554.
|
[8] | Podbielska M, Krotkiewski H, Hogan EL (2012) Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis. Neurochem Res 37: 1154-1169. doi:10.1007/s11064-012-0728-y. PubMed: 22451227.
|
[9] | Chabowski A, Zendzian-Piotrowska M, Mik?osz A, ?ukaszuk B, Kurek K et al. (2013) Fiber specific changes in sphingolipid metabolism in skeletal muscles of hyperthyroid rats. Lipids 48: 697-704. doi:10.1007/s11745-013-3769-3. PubMed: 23467817.
|
[10] | Baranowski M, Charmas M, D?ugo??cka B, Górski J (2011) Exercise increases plasma levels of sphingoid base-1 phosphates in humans. Acta Physiol (Oxf) 203: 373-380. doi:10.1111/j.1748-1716.2011.02322.x. PubMed: 21535416.
|
[11] | Park JW, Park WJ, Kuperman Y, Boura-Halfon S, Pewzner-Jung Y et al. (2013) Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology 57: 525-532. doi:10.1002/hep.26015. PubMed: 22911490.
|
[12] | Bosma M, Kersten S, Hesselink MK, Schrauwen P (2012) Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity. Prog Lipid Res 51: 36-49. doi:10.1016/j.plipres.2011.11.003. PubMed: 22120643.
|
[13] | Schmitz-Peiffer C, Craig DL, Biden TJ (1999) Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274: 24202-24210. doi:10.1074/jbc.274.34.24202. PubMed: 10446195.
|
[14] | Hajduch E, Balendran A, Batty IH, Litherland GJ, Blair AS et al. (2001) Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44: 173-183. doi:10.1007/s001250051596. PubMed: 11270673.
|
[15] | Watson ML, Coghlan M, Hundal HS (2009) Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells. Biochem J 417: 791-801. doi:10.1042/BJ20081149. PubMed: 18922131.
|
[16] | Pickersgill L, Litherland GJ, Greenberg AS, Walker M, Yeaman SJ (2007) Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem 282: 12583-12589. doi:10.1074/jbc.M611157200. PubMed: 17337731.
|
[17] | Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA et al. (2004) Ceramide content is increased in skeletal muscle from obese insulin resistant humans. Diabetes 53: 25-31. doi:10.2337/diabetes.53.1.25. PubMed: 14693694.
|
[18] | Stratford S, Hoehn KL, Liu F, Summers SA (2004) Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 279: 36608-36615. doi:10.1074/jbc.M406499200. PubMed: 15220355.
|
[19] | Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E et al. (2007) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50: 2366-2373. doi:10.1007/s00125-007-0781-2. PubMed: 17724577.
|
[20] | Bikman BT, Summers SA (2011) Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 121: 4222-4230. doi:10.1172/JCI57144. PubMed: 22045572.
|
[21] | Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT et al. (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278: 10297-10303. doi:10.1074/jbc.M212307200. PubMed: 12525490.
|
[22] | Powell DJ, Turban S, Gray A, Hajduch E, Hundal HS (2004) Intracellular ceramide synthesis and protein kinase Cz activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J 382: 619-629. doi:10.1042/BJ20040139. PubMed: 15193147.
|
[23] | Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM et al. (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5: 167-179. doi:10.1016/j.cmet.2007.01.002. PubMed: 17339025.
|
[24] | Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H et al. (2005) SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280: 37118-37129. doi:10.1074/jbc.M502207200. PubMed: 16118219.
|
[25] | Ma MM, Chen JL, Wang GG, Wang H, Lu Y et al. (2007) Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in KK/Ay diabetic mice. Diabetologia 50: 891-900. doi:10.1007/s00125-006-0589-5. PubMed: 17265031.
|
[26] | Bruce CR, Risis S, Babb JR, Yang C, Kowalski GM et al. (2012) Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 61: 3148-3155. doi:10.2337/db12-0029. PubMed: 22961081.
|
[27] | Seyoum B, Fite A, Abou-Samra AB (2011) Effects of 3T3 adipocytes on interleukin-6 expression and insulin signaling in L6 skeletal muscle cells. Biochem Biophys Res Commun 410: 13-18. doi:10.1016/j.bbrc.2011.05.073. PubMed: 21640704.
|
[28] | Zhang C, He H, Zhang H, Yu D, Zhao W et al. (2013) The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells. Biochem Biophys Res Commun 434: 35-41. doi:10.1016/j.bbrc.2013.03.070. PubMed: 23545258.
|
[29] | Miklosz A, Chabowski A, Zendzian-Piotrowska M, Gorski J (2012) Effects of hyperthyroidism on lipid content and composition in oxidative and glycolytic muscles in rats. J Physiol Pharmacol 63: 403-410. PubMed: 23070090.
|
[30] | Min JK, Yoo HS, Lee EY, Lee WJ, Lee YM (2002) Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal Biochem 303: 167-175. doi:10.1006/abio.2002.5579. PubMed: 11950216.
|
[31] | Bose R, Chen P, Loconti A, Grüllich C, Abrams JM et al. (1998) Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35. J Biol Chem 273: 28852-28859. doi:10.1074/jbc.273.44.28852. PubMed: 9786886.
|
[32] | Dekker MJ, Baker C, Naples M, Samsoondar J, Zhang R et al. (2013) Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: Evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction. Atherosclerosis 228: 98-109. doi:10.1016/j.atherosclerosis.2013.01.041. PubMed: 23466071.
|
[33] | Kolter T (2011) A view on sphingolipids and disease. Chem Phys Lipids 164: 590-606. doi:10.1016/j.chemphyslip.2011.04.013. PubMed: 21570958.
|
[34] | Chavez JA, Summers SA (2010) Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim Biophys Acta 1801: 252-265. doi:10.1016/j.bbalip.2009.09.015. PubMed: 19796706.
|
[35] | Aerts JM, Boot RG, Eijk M, Groener J, Bijl N et al. (2011) Glycosphingolipids and insulin resistance. Adv Exp Med Biol 721: 99-119. doi:10.1007/978-1-4614-0650-1_7. PubMed: 21910085.
|
[36] | Dubé JJ, Amati F, Toledo FG, Stefanovic-Racic M, Rossi A et al. (2011) Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia 54: 1147-1156. doi:10.1007/s00125-011-2065-0. PubMed: 21327867.
|
[37] | Holland WL, Summers SA (2008) Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 29: 381-402. doi:10.1210/er.2007-0025. PubMed: 18451260.
|
[38] | Bruce CR, Risis S, Babb JR, Yang C, Lee-Young RS et al. (2013) The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice. Endocrinology 154: 65-76. doi:10.1210/en.2012-1847. PubMed: 23183172.
|
[39] | Lam YY, Hatzinikolas G, Weir JM, Janovská A, McAinch AJ et al. (2011) Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta 181: 468-475. PubMed: 21570480.
|
[40] | Wang L, Xing XP, Holmes A, Wadham C, Gamble JR et al. (2005) Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res 9: 891-899. PubMed: 16179586.
|
[41] | Takabe K, Paugh SW, Milstien S, Spiegel S (2008) "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2: 181-195.
|
[42] | Bruni P, Donati C (2008) Pleiotropic effects of sphingolipids in skeletal muscle. Cell Mol Life Sci 65: 3725-3736. doi:10.1007/s00018-008-8236-6. PubMed: 18668202.
|
[43] | Coen PM, Goodpaster BH (2012) Role of intramyocelluar lipids in human health. Trends Endocrinol Metab 8: 391-398. PubMed: 22721584.
|
[44] | Hu W, Bielawski J, Samad F, Merrill AH Jr, Cowart LA (2009) Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity. J Lipid Res 9: 1852-1862. PubMed: 19369694.
|
[45] | Ussher JR, Koves TR, Cadete VJJ, Zhang L, Jaswal JS et al. (2010) Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59: 2453-2464. doi:10.2337/db09-1293. PubMed: 20522596.
|
[46] | Frangioudakis G, Garrard J, Raddatz K, Nadler JL, Mitchell TW et al. (2010) Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. Endocrinology 9: 4187-4196. PubMed: 20660065.
|
[47] | Kono M, Allende ML, Proia RL (2008) Sphingosine-1-phosphate regulation of mammalian development. Biochim Biophys Acta 1781: 435-441. doi:10.1016/j.bbalip.2008.07.001. PubMed: 18675379.
|
[48] | Yang G, Badeanlou L, Bielawski J, Roberts AJ, Hannun YA et al. (2009) Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 297: E211-E224. doi:10.1152/ajpendo.91014.2008. PubMed: 19435851.
|
[49] | Kotelevets N, Fabbro D, Huwiler A, Zangemeister-Wittke U (2012) Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis. PLOS ONE 6: e39209-e39222.
|
[50] | Watt MJ, Hoy AJ (2012) Lipid metabolism in skeletal muscle: generation of adaptive and maladaptive intracellular signals for cellular function. Am J Physiol Endocrinol Metab 302: E1315-E1328. doi:10.1152/ajpendo.00561.2011. PubMed: 22185843.
|
[51] | Rapizzi E, Taddei ML, Fiaschi T, Donati C, Bruni P et al. (2009) Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. Cell Mol Life Sci 66: 3207-3218. doi:10.1007/s00018-009-0106-3. PubMed: 19662499.
|
[52] | Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22: 50-60. doi:10.1016/j.tcb.2011.09.003. PubMed: 22001186.
|
[53] | Johnson KR, Becker KP, Facchinetti MM, Hannun YA, Obeid LM (2002) PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277: 35257-35262. doi:10.1074/jbc.M203033200. PubMed: 12124383.
|
[54] | Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE et al. (2003) Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278: 40330-40336. doi:10.1074/jbc.M304455200. PubMed: 12835323.
|